References
Wiseman LR, Faulds D. Drugs 47: 116–152, 1994
Drenth JPH, Engels LGJB. Drugs 44: 537–553, 1992
Holtmann G, Talley NJ. Drugs 45: 918–930, 1993
Bianchi Porro G, Pace F. J Intern Med 234: 387–396, 1993
Barradell LB, McTavish D. PharmacoEconomics 3: 482–510, 1993
Bate CM, Richardson PDI PharmacoEconomics 3: 94–99, 1993
Van Outryve M, et al. Scand J Gastroenterol 28 (Suppl. 195): 47–53, 1993
McCallum, et al. Drugs 36: 652–681, 1988
Maleev A, et al. Hepatogastroenterology 37: 403–407, 1990
Duvas A, et al. II United European Gastroenterology Week, Barcelona, Jul 19–24. Abstract No. 170, 1993
Weinbeck M, Ranpride Study Group II. International Symposium on Pharmacotherapy of Gastrointestinal Motor Disorders, Adelaide, South Australia, 2–4 Sep, 1990
Kishi S, et al. Shinryo to Shinyaku 29: 1608–1618, 1992
Sekiguchi T, et al. Gastroenterol Jpn 26: 137–144, 1991
Mundo F, et al. Am J Gastroenterol 87: 1254, 1992
Blum AL, et al. Dig Dis Sci 38: 551–560, 1993
Tytgat GNJ, et al. Scand J Gastroenterol 27: 175–183, 1992
Toussaint J, et al. Gut 32: 1280–1285, 1991
Gonzàlez-Galicia JA, et al. Invest Médica Intern 19: 10–15, 1992
Mundo F, et al. Am J Gastroenterol 85: 1222, 1990
Greally P, et al. Arch Dis Child 67: 618–621, 1992
Wolfsen HC, Patterson DJ. Am J Gastroenterol 84: A134, 1989
De Caestecker JS, et al. Aliment Pharmacol Ther 3: 69–81, 1989
Champion MC, et al. Am J Gastroenterol 86: 1309, 1991
Hauksen T, et al. Scand J Gastroenterol 27: 213–217, 1992
Verlinden M, et al. In Johnson & Lux (Eds) Progress in the treatment of gastrointestinal motility disorders: the role of cisapride., pp 30–36, Excerpta Medica, Amsterdam, 1988
Inpharma 873: 22, 1993
Rights and permissions
About this article
Cite this article
Cisapride: an alternative to other prokinetic and antisecretory agents in gastrointestinal motility disorders. Drugs Ther. Perspect 3, 1–4 (1994). https://doi.org/10.2165/00042310-199403100-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199403100-00001